FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to an anti-CEACAM1 antibody or its fragment. A method for treating cancer, a method for inhibiting the proliferation of CEACAM1-expressing tumor cells using the specified antibody, and the use of the specified antibody for the prevention or treatment of cancer are also proposed.
EFFECT: invention makes it possible to effectively treat cancer related to overexpression of CEACAM1.
28 cl, 29 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROGRAMMED CELL DEATH (PD-1) PROTEIN-1 ANTIBODIES AND USE THEREOF | 2017 |
|
RU2725950C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY SPECIFICALLY BINDING WITH THE N-TERMINAL OF LYSYL-TRNA SYNTHETASE AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY CELL MIGRATION | 2018 |
|
RU2749591C1 |
| ANTIBODIES AGAINST HUMAN VSIG4 AND APPLICATION THEREOF | 2019 |
|
RU2776638C1 |
| ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION | 2018 |
|
RU2745451C1 |
| NEW ANTI-C-MET-ANTIBODY AND APPLICATION THEREOF | 2018 |
|
RU2751720C2 |
| ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 |
|
RU2801535C1 |
| MICROORGANISM PRODUCING PUTRESCINE OR ORNITHINE AND METHOD FOR PRODUCING PUTRESCINE OR ORNITHINE USING THIS MICROORGANISM | 2016 |
|
RU2759956C1 |
| SPECIFIC TO MUCIN-1 POLYPEPTIDE AND ITS USE | 2021 |
|
RU2805840C1 |
| MICROORGANISMS FOR PRODUCING ORNITHINE AND METHOD OF PRODUCING ORNITHINE USING SAID MICROORGANISMS | 2016 |
|
RU2721852C1 |
| ANTIBODY-DRUG CONJUGATES INCLUDING ANTIBODY AGAINST HUMAN DLK1 AND THEIR USE | 2020 |
|
RU2801630C2 |
